However, a few other studies suggested the antimotility role of MK5 in HeLa and U2OS osteosarcoma cells where MK5 exerts its function through the impairment of FAK activation and filamentous actin formation, respectively [22, 23]. Here, MAPKAPK5 is linked to osteosarcoma.